TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07810491: Telemedicine Technology Supporting the Diagnostic Process Based on Automated Analysis of Laboratory Test Results With a Structured Medical History: A Prospective, Two-Center, Two-Phase Clinical Validation Study

Sponsor: Labplus Sp. z o.o. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 899 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$10,624,000

Rescue Site Savings

+$7,005,200

Unlock Full NCT07810491 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07810491 Rescue Dossier →